National Institute on Drug Abuse; Notice of Closed Meetings

<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>National Institute on Drug Abuse; Notice of Closed Meetings</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> National Institute on Drug Abuse Special Emphasis Panel; Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications. <E T="03">Date:</E> May 5-6, 2025. <E T="03">Time:</E> 10:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Sindhu Kizhakke Madathil, Ph.D., Scientific Review Officer, Division of Extramural Research, Scientific Review Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 827-5702, <E T="03">sindhu.kizhakkemadathil@nih.gov</E> . <E T="03">Name of Committee:</E> National Institute on Drug Abuse Special Emphasis Panel; Mechanism for Time-Sensitive Drug Abuse Research. <E T="03">Date:</E> May 5, 2025. <E T="03">Time:</E> 1:00 p.m. to 1:30 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Sudhirkumar U. Yanpallewar, M.D., Scientific Review Officer, Scientific Review Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 443-4577, <E T="03">sudhirkumar.yanpallewar@nih.gov</E> . <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED>Dated: March 14, 2025.</DATED> <NAME>David W. Freeman, </NAME> Supervisory Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-04588 Filed 3-18-25; 8:45 am]</FRDOC> </NOTICE>